Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR): A Randomized Multi-center Study for Men With Newly Diagnosed Favorable Risk Prostate Cancer

NCT04396808 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.

NCT NCT04396808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04396808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR): A Randomized Multi-center Study for Men With Newly Diagnosed Favorable Risk Prostate Cancer
Lead sponsor
University of Michigan Rogel Cancer Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 5, 2020
Completion date
March 31, 2031
Enrollment
805 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer